Evidence map›Paper›PMID 24121924›Full record

ReviewMedicina oral, patologia oral y cirugia bucal2013

Clinical diseases with thrombotic risk and their pharmacologycal treatment: how they change the therapeutic attitude in dental treatments.

Federico Martínez-López, Ricardo Oñate-Sánchez, Juan-José Arrieta-Blanco, Daniel Oñate-Cabrerizo, Maria-del Carmen Cabrerizo-Merino

Open access · diamondAbstract readReview
In one paragraph

Review in Medicina oral, patologia oral y cirugia bucal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Implications of apixaban for dental treatments.Journal of clinical and experimental dentistry · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Federico Martínez-LópezUnidad Docente de Pacientes Especiales, Clínica Odontológica Universitaria, 2 Planta Hospital Morales Meseguer, Avenida Marqués de los Vélez s/n, 30.008 Murcia, reosan@um.es.
Ricardo Oñate-Sánchez
Juan-José Arrieta-Blanco
Daniel Oñate-Cabrerizo
Maria-del Carmen Cabrerizo-Merino
Department of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new antiplatelets and anticoagulant drugs have been recently introduced in the daily medical practices for the control of thromboembolism associated with different diseases. The dental assistance of these patients forces us to know these drugs, understand their action mechanisms and try to decrease the risks that entail ours actions in these patients, making a thorough analysis of the risk of bleeding that is going to be related to our medical intervention, as well as the use of all the control measures of the hemorrhage from our knowledge with these patients, and to be prudent. The communication with the medical specialist that supervises these patients must be maxim, being necessary to make clinic trials for establishing protocols or guides of the handling with these patients during the odontological treatment.

Indexed as

Dental CareAnticoagulantsHumansPlatelet Aggregation InhibitorsPractice Guidelines as TopicRisk FactorsThrombosisAnticoagulantsPlatelet Aggregation Inhibitors

Identifiers

PMID24121924
PMCPMC3854082
OpenAlexW2143750936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.